Natura Biotechnol Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.55 Cr
as on 15-11-2024
- Revenue 16.39%
(FY 2023)
- Profit 18.85%
(FY 2023)
- Ebitda 18.54%
(FY 2023)
- Net Worth 20.30%
(FY 2023)
- Total Assets 30.39%
(FY 2023)
About Natura Biotechnol
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.55 Cr.
The Key Managerial Personnel (KMP) at Natura Biotechnol Private Limited India is Pankaj Varshney as CEO. Sudha Chaturvedi, Namrata Sheel, Shekhar Chaturvedi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909KA2012PTC063207
- Company No.
063207
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Natura Biotechnol Private Limited offer?
Natura Biotechnol Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Plant Extracts, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Medicinal Plant.
Who are the key members and board of directors at Natura Biotechnol?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Chaturvedi  | Managing Director | 26-Mar-2012 | Current |
| Pankaj Varshney | CEO | 15-Dec-2020 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Namrata Sheel | Director | 26-Mar-2012 | Current |
| Shekhar Chaturvedi | Director | 01-Jul-2015 | Current |
| Pankaj Varshney | Director | 01-Jul-2015 | Current |
Financial Performance of Natura Biotechnol.
Natura Biotechnol Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.39% increase. The company also saw a substantial improvement in profitability, with a 18.85% increase in profit. The company's net worth Soared by an impressive increase of 20.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natura Biotechnol?
In 2023, Natura Biotechnol had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Natura Ayur Science Private LimitedActive 1 year 8 monthsSudha Chaturvedi and Shekhar Chaturvedi are mutual person
- Natura Herbal Ashram LlpActive 5 years 10 months
Namrata Sheel and Pankaj Varshney are mutual person
- Appodeepo Technology Solutions Private LimitedActive 7 years 1 month
Shekhar Chaturvedi is a mutual person
Charges (Loans)
₹15.49 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 1.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2018 | Idbi Bank Limited | ₹1.55 Cr | Open |
How Many Employees Work at Natura Biotechnol?
Natura Biotechnol has a workforce of 22 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natura Biotechnol, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natura Biotechnol's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.